Pharmacists’ participation in the documentation of medication history in a developing setting: An exploratory assessment with new criteria

Main Article Content

Kazeem B. Yusuff
Fola Tayo
Bolajoko A. Aina


Medical Records, Pharmacists, Nigeria


Objective: To assess the impact of pharmacists’ participation on the frequency and depth of medication history information documented in a developing setting like Nigeria

Method: The study consisted of two phases. The first phase was a baseline cross-sectional assessment of the frequency and depth of medication history information documented by physicians in case notes of systematic samples of 900 patients that were stratified over 9 Medical outpatients Units at a premier teaching hospital in south western Nigeria. The second phase was an exploratory study involving 10 pharmacists who conducted cross-sectional medication history interview for 324 randomly selected patients.

Results: 49.2% of patients, whose medication history were documented at the baseline, by physicians, were males; while 50.3% of patient interviewed by pharmacists were male. Mean age (SD) of males and females whose medication histories were documented by physicians and pharmacists were 43.2 (SD=18.6), 43.1 (SD=17.9) years and 51.5 (SD=17.6), 52.1 (SD=17.4) years respectively. The frequency of medication history information documented by pharmacists was significantly higher for twelve of the thirteen medication history components (P < 0.0001). These include prescription medicines; over the counter medicines; source of medicines; adverse drug reactions; allergy to drugs, allergy to foods, allergy to chemicals; patient adherence; alcohol use; cigarette smoking; dietary restrictions and herbal medicine use. The depth of medication history information acquired and documented by pharmacist was significantly better for all the thirteen medication history components (P<0.0001).

Conclusion: Pharmacists’ participation resulted in significant increase in frequency and depth of medication history information documented in a developing setting like Nigeria. The new medication history evaluation criteria proved useful in assessing the impact of pharmacists’ participation.


Download data is not yet available.
Abstract 1313 | PDF Downloads 776


1. Covington TR. Interviewing and advising patients. In Francke DE, Whitney HAK Jr. eds. Perspectives in Clinical Pharmacy, 1st edition, Illinois: Hamilton 1972.

2. Tietzie K. Clinical skills for pharmacists, a patient-focused approach. Mosby-year book inc. St Loius, Missouri. USA, 1997;39-40.

3. Cohen J, Wilson C, Ward F. Improve drug history taking. Pharmacy in Practice.1998;1:13-16.

4. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape L, Bates DW. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-1564.

5. Wilcock M, Lawrence J. Is there a role for community pharmacists in identifying discrepancies in medication histories for patients admitted to hospital? Pharm J. 2004;272:253-256.

6. Beers MH, Munekata M, Storrie M. The accuracy of medication histories in the hospital medical records of elderly persons. J Am Geriatr Soc. 1990;38:1183-1187.

7. Batty GM, Oborne CA, Swift CG, Jackson SH. The use of over-the-counter medication by elderly medical inpatients. Postgrad Med J. 1997;73(865):720-722.

8. Bedell SE, Jabbour S, Goldberg R, Glaser H, Gobble S, Young-Xu Y, Graboys TB, Ravid S. Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med. 2000;160:2129-2134.

9. Yusuff KB, Awotunde M. The frequency of drug history documentation in an institutionalized tertiary care setting in Nigeria. J Pharm Pharm Sci. 2005; 8(2):140-145.

10. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. Can Med Assoc J. 2005;173(5):510-515.

11. Gleason KM, Groszek JM, Sullivan C, Rooney D, Barnard C, Noskin GA. Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health-Syst Pharm. 2004;61:1689-1695.

12. Massey C. An evaluation of the benefits of pharmacist-acquired drug histories. Proc Guild Hosp Pharm.1987;25:80-81.

13. Montpetit LM, Roy MT. Evaluation of a patient-completed versus health professional-conducted medication history. Drug Intell Clin Pharm. 1988;16:592-595.

14. Hocking G, Kalyanaraman R, deMello WF. Better drug history taking: an assessment of the drug mnemonic. J R Soc Med. 1998;91:305-306.

15. Nester TM, Hale LS. Effectiveness of a pharmacist-acquired medication history in promoting patient safety. Am J Health-Syst Pharm. 2002;59(22):2221-2225.

16. Gurwich EL. Comparison of medication histories acquired by pharmacists and physicians. Am J Hosp Pharm.1983;40:1541-1542.

17. Akwagyriam I, Goodyer LI, Harding L, Khakoo S, Millington H. Drug history taking and the identification of related problems in an accident and emergency department. J Accid Emerg Med. 1996;13:166-168.

18. McRobbie D, Bednall R, West T. Assessing the impact of re-engineering of pharmacy services to general medical wards. Pharm J. 2003;270:342-345.

19. Eniojukan JF, Aina BA, Tijani MM. Drug distribution network in Nigeria Nig Quart J Hosp Med. 1997;7:384-389.

20. Erhun WO, Babalola OO, Erhun MO. Drug regulation and control in Nigeria: The challenge of counterfeit drugs. J Health Pop Develop Countries. 2001;4(2):23-34.

21. Taylor RB, Sharkoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, Reid RG, Kolawole JA. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet. 2001;357(9272):1933-1936.

22. Ositelu A. Ocular drug abuse in Lagos, Nigeria. Acta Opthalmologica 1989;67:396-400.

23. Erhun WO, Agunedu CO. Procurement and sale of drugs in a market-place. Nig J Pharm. 1995;26:30-32.

24. Ajayi IO, Falade CO. Pre-hospital treatment of febrile illness in children attending the General Outpatient Clinic, University College Hospital, Ibadan, Nigeria. Afr J Med Med Sci. 2006;35:85-91.

25. Dunne J. Deadly medicines: the cost of substandard drugs. Medicine Digest 1997;23:5-7.

26. Maponga C, Odari C. The quality of antimalarial; A study in selected African countries. World Health Organization. Geneva. WHO/EDM/PAR. 2003;4:1-54.

27. Alubo SA. Drugging the people: pills, profits and underdevelopment in Nigeria. Studies in Third World Societies. 1985;24:89-113.

28. Bouwmeester M, Laberge N, Bussieres J, Lebel D, Bailey B, Harel F. Program to remove incorrect allergy documentation in pediatrics medical records. Am J Health-Syst Pharm. 2001;58:1722-1727.

29. Geibig CB, Mansur JM, Medema PG. Pharmacy-controlled documentation of drug allergies. Am J Hosp Pharm. 1991;48:260-264.

30. Tripp DM, Brown GR. Pharmacist assessment of drug allergies. Am J Hosp Pharm. 1993;50:95-98.

31. Bieszk N. Detection of medication non-adherence through review of pharmacy claims data. Am J Health-Syst Pharm. 2003;60(4):360-366.

32. Badowski SA, Rosenbloom D, Dawson PH. Clinical importance of pharmacist-obtained medication histories using a validated questionnaire. Am J Hosp Pharm. 1984;41:731-732.

33. Cradock JC, Whitefield GR, Menzie JW. Post-admission drug allergy histories recorded by pharmacists. Am J Hosp Pharm. 1972;29:250-252.